The US Food and Drug Administration is revamping its quality metrics program by incorporating elements of various initiatives already underway, an agency official told a recent conference.
Those initiatives include pilots undertaken by the pharmaceutical industry, the agency and academia as well as the FDA's site engagement program, which has yielded some lessons learned, according to a...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?